Literature DB >> 7957410

Comparison of the bronchodilating effect of oxitropium bromide and fenoterol in asthmatic children.

H P Van Bever1, K N Desager, J H Pauwels, P A Vermeire.   

Abstract

Using a randomized double blind study design, the bronchodilating effect of 200 micrograms inhaled oxitropium bromide (OB) was compared with 200 micrograms inhaled fenoterol (F) after an interval of 20 min, in 20 asthmatic children aged 12.7 years (range: 4.9-15.1 years), suffering from mild bronchoconstriction (mean forced expiratory volume during ls: 73.4%, range: 51%-85%). Both drugs induced a comparable degree of bronchodilatation and no significant differences were found between the OB group and the F group, suggesting equipotency for both drugs after a 20 min interval, at the 200 micrograms dose level. Furthermore, a significant improvement of lung function parameters was detected in both groups after subsequent administration of 400 micrograms F, indicating that inhalation of 200 micrograms of OB or F results in submaximal bronchodilation in asthmatic children suffering from mild bronchoconstriction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957410     DOI: 10.1007/BF02190670

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  A cumulative dose response study of oxitropium bromide (Ba 253) in asthmatics.

Authors:  J C Pounsford; R W Fuller; K B Saunders
Journal:  Eur J Respir Dis Suppl       Date:  1983

2.  [Pharmacologic modification of effort dyspnea in children with CARA].

Authors:  H J Neijens; T R Wesselius; K F Kerrebijn
Journal:  Ned Tijdschr Geneeskd       Date:  1981-08-08

3.  Duration of protection by oxitropium bromide against cholinergic challenge.

Authors:  N M Wilson; S Green; C Coe; P J Barnes
Journal:  Eur J Respir Dis       Date:  1987-11

4.  A dose response study of oxitropium bromide in chronic bronchitis.

Authors:  E T Peel; G Anderson
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

5.  Central versus peripheral airway obstruction in bronchial responsiveness due to exercise.

Authors:  H J Neijens; G Gargani; A van Kralingen; N van Weezepoel; K F Kerrebijn
Journal:  Eur J Respir Dis Suppl       Date:  1982

6.  Double-blind crossover comparison between a beta-adrenergic agent and a new anticholinergic agent by metered dose inhaler.

Authors:  D Nolte
Journal:  Respiration       Date:  1978       Impact factor: 3.580

7.  Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.

Authors:  P A Frith; B Jenner; R Dangerfield; J Atkinson; C Drennan
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

8.  Oxitropium bromide, a new anticholinergic bronchodilator.

Authors:  M S Skorodin; N J Gross; T Moritz; F W King; W Armstrong; D Wells; E Galavan; L Slutsky
Journal:  Ann Allergy       Date:  1986-03

9.  Exercise-induced bronchoconstriction as an expression of bronchial hyperreactivity: a study of its mechanisms in children.

Authors:  H J Neijens; T Wesselius; K F Kerrebijn
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

10.  Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.

Authors:  B G Higgins; R M Powell; S Cooper; A E Tattersfield
Journal:  Eur Respir J       Date:  1991-04       Impact factor: 16.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.